PDGFRB and autosomal recessive polycystic kidney disease: Immunostaining of whole-mount organoids indicated that treatment with 10 μM concentrations of PDGFR inhibitors (Imatinib, Crenolanib) significantly decreased collagen formation in ARPKD organoids (p < 0.001) (Fig. 7a).